Seeking Alpha

Having been criticized for failing to spot problems with drugs such as Merck's (MRK) Vioxx...

Having been criticized for failing to spot problems with drugs such as Merck's (MRK) Vioxx painkiller, the European Medicines Agency plans to make large sets of clinical data publicly available, catapulting the bloc ahead of the U.S. for transparency. Scientists hope to use the data to test the claims of drug firms, and to find new treatment methods.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector